Skip to main content

UBS Group AG

Position in ICCC — Immucell Corp /De/

CIK 1610520 ZURICH, V8

Position in ICCC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$10,050
+$3,005 QoQ
Shares Held
1,000
-10.2% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 30 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ICCC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,173,304 across 562 Biotechnology names. ICCC ranks #446 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ICCC

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,050 1,000
2026-03-31 $7,045 1,113
2025-12-31 $9,907 1,611
2025-09-30 $6,250 1,000
2025-06-30 $58,401 8,391
2025-03-31 $80,907 16,891
2024-12-31 $64,787 12,580
2024-09-30 $57,869 15,942
2024-06-30 $12,973 2,675
2024-03-31 $23,585 4,450
2023-12-31 $7,635 1,500
2023-09-30 $8,522 1,596
2023-06-30 $8,500 1,700
2023-03-31 $9,267 1,796
2022-12-31 $9,150 1,500
2022-09-30 $11,220 1,500
2022-06-30 $23,011 2,648
2022-03-31 $18,971 1,966
2021-12-31 $18,784 2,348
2021-09-30 $21,977 2,348
2021-06-30 $19,950 2,100
2021-03-31 $20,244 2,100
2020-12-31 $20,033 3,367
2020-09-30 $12,575 2,316
2020-06-30 $9,933 2,100
2020-03-31 $7,959 2,100